Erythrocyte survival tests in cases of anti-AnWj antibodies.
van Gaalen
F A
FA
Zanin
D E A
DE
Brand
A
A
D000743:Anemia, Hemolytic / Q000209:etiology / Q000628:therapy; D001789:Blood Group Antigens / Q000276:immunology*; D001787:Blood Group Incompatibility / Q000097:blood* / Q000276:immunology; D002699:Chlorambucil / Q000627:therapeutic use; D003298:Coombs Test; D004905:Erythrocyte Aging; D017707:Erythrocyte Transfusion / Q000009:adverse effects*; D017809:Fatal Outcome; D006333:Heart Failure / Q000150:complications; D006801:Humans; D007114:Immunization; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D007518:Isoantibodies / Q000097:blood / Q000276:immunology; D008297:Male; D008875:Middle Aged; D018805:Sepsis / Q000150:complications; D008258:Waldenstrom Macroglobulinemia / Q000097:blood / Q000150:complications / Q000188:drug therapy
D001789:Blood Group Antigens; D007074:Immunoglobulin G; D007518:Isoantibodies; D002699:Chlorambucil